Second-Generation Peptidomimetic Inhibitors of Antigen Presentation Effectively Treat Autoimmune Diseases in HLA-DR-transgenic Mouse Models

Journal of Autoimmunity - United States
doi 10.1016/j.jaut.2006.09.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Animal Models in Autoimmune Diseases: Lessons Learned From Mouse Models for Sjögren’s Syndrome

Clinical Reviews in Allergy and Immunology
MedicineAllergyImmunology
2011English

HLA-G Molecules in Autoimmune Diseases and Infections

Frontiers in Immunology
AllergyImmunology
2014English

Transgenic Models of Skin Diseases

Archives of Dermatology
1993English

Lessons Learned From Transgenic Mouse Models for the Therapeutic Use of Drp1 Inhibitors

Single Cell Biology
2016English

Transgenic Mouse Models for ADHD

Cell and Tissue Research
Forensic MedicinePathologyHistologyCell Biology
2013English

The Convergent Roles of Tapasin and HLA-DM in Antigen Presentation

Trends in Immunology
AllergyImmunology
2008English

Improved Murine-MHC-Deficient HLA-Transgenic NOD-Mouse Models for Type 1 Diabetes Therapy Development

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Expression of Hla-Dr Antigen on Head and Neck Carcinomas

Journal of Otolaryngology of Japan
Otorhinolaryngology
1993English

Transgenic Mouse Models of Alzheimer's Disease

Biochemical Society Transactions
Biochemistry
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy